BNO 5.26% 20.0¢ bionomics limited

I listened to most of the conference call, but my NBN locked up...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 912 Posts.
    lightbulb Created with Sketch. 95
    I listened to most of the conference call, but my NBN locked up and I was thrown off half way through the Q&A. Sounds like PTSD is finished for BNC210. The Placebo group caught up to the patients under test. Now all eyes turn to the Agitated behavioral disturbance in elderly patients trial. BNC210 is better suited to Depression and Anxiety disorders than PTSD. I hope they put a recording of the call up later. Will have to hear what their strategic review comes up with when they present the results at the AGM. Main issue now is cash burn, although that wasn't talked about during the conference call.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.